Skip to main content

Table 3 Drugs with claim count differences where adjusted P value is lower than 0.05

From: Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database

Drug name

Total matched pairs

Drug users—mean AD claim count

Non-users—mean AD claim count

Paired T-test statistic

Raw P value

Inflation-adjusted P value

Corrected P value

Drug description

Decreased healthcare utilization

Penicillin V

2635

3.93

4.63

 − 4.23

2.34E − 05

3.28E − 03

1.98E − 01

Antibiotic

Donepezil

22,005

4.16

4.44

 − 4.15

3.40E − 05

3.96E − 03

1.98E − 01

Treats AD

Sodium sulfate

6218

4.03

4.51

 − 3.90

9.55E − 05

6.68E − 03

2.40E − 01

Laxative

Clavulanate

10,721

4.16

4.52

 − 3.45

5.72E − 04

1.66E − 02

4.75E − 01

Antibiotic supp

Albuterol

9806

4.18

4.53

 − 3.32

8.95E − 04

2.09E − 02

4.96E − 01

Asthma

Sodium chloride

5789

4.03

4.43

 − 3.23

1.24E − 03

2.48E − 02

4.96E − 01

Electrolyte

Celecoxib

2629

4.01

4.60

 − 3.17

1.56E − 03

2.79E − 02

5.06E − 01

Inflammation

Amoxicillin

18,298

4.22

4.45

 − 2.94

3.28E − 03

4.10E − 02

6.52E − 01

Antibiotic

Potassium chloride

11,608

4.20

4.45

 − 2.92

3.50E − 03

4.24E − 02

6.52E − 01

Electrolyte

Increased healthcare utilization

Quetiapine

5379

5.12

4.36

5.33

1.01E − 07

2.14E − 04

4.28E − 02

Schizophrenia

Valproate

1643

5.30

4.19

4.48

7.63E − 06

1.86E − 03

1.86E − 01

Seizures

Lorazepam

7199

4.82

4.36

3.87

1.11E − 04

7.21E − 03

2.40E − 01

Seizures

Trazodone

5538

4.73

4.29

3.29

1.02E − 03

2.24E − 02

4.96E − 01

Anti-depressant

  1. Decreased healthcare utilization, where drug users have fewer claims than non-users, is on the top table; increased healthcare utilization, where drug users had more claims than non-users, is displayed in the lower table